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ScienceDirectAlthough typically viewed as a feature of innate immune
responses, microbial pattern recognition is increasingly
acknowledged as a function of particular cells nominally
categorized within the adaptive immune system.
Groundbreaking research over the past three years has shown
how unconventional human T-cells carrying invariant or semi-
invariant TCRs that are not restricted by classical MHC
molecules sense microbial compounds via entirely novel
antigen presenting pathways. This review will focus on the
innate-like recognition of non-self metabolites by Vg9/Vd2 T-
cells, mucosal-associated invariant T (MAIT) cells and
germline-encoded mycolyl-reactive (GEM) T-cells, with an
emphasis on early immune responses in acute infection.
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Introduction
The human body is constantly exposed to a vast array of
microorganisms through contact with environmental spe-
cies and interactions with commensals, opportunists and
pathogens. This microbial bombardment exerts a perpet-
ual evolutionary pressure on the immune system to
identify and eliminate potentially dangerous agents.
Microbes express a plethora of pathogen-associated mo-
lecular patterns that engage with various components of
the human immune system, triggering rapid and distinct
responses as a first-line defense against specific groups
of organisms. The innate recognition of such patterns* These authors contributed equally.
www.sciencedirect.com ultimately induces unique clusters of immune and tissue-
related biomarkers that coalesce as pathogen-specific
‘immune fingerprints’ [1,2], with widespread implica-
tions for point-of-care diagnosis of acute infection.
In the adaptive immune system, somatic recombination
of V(D)J gene segments and junctional modifications
generate a diverse repertoire of clonotypically expressed
TCRs, enabling antigenic peptide-specific T-cell
responses restricted by MHC class I and class II mole-
cules. Although such genomic rearrangements occur in all
T-cells, ‘unconventional’ populations characterized by
semi-invariant, invariant or even germline-encoded
TCRs are universally present and serve to recognize
alternative antigens that are not restricted by classical
MHC molecules. Research over the past three years has
exposed how unconventional T-cells detect pathogens by
sensing microbial, non-peptidic compounds via entirely
novel antigen presenting pathways. High throughput
sequencing approaches have also hinted at the existence
of further unconventional T-cell subsets [3]. This review
will focus primarily on the innate-like recognition of non-
self metabolites by human Vg9/Vd2 T-cells, mucosal-
associated invariant T (MAIT) cells and germline-
encoded mycolyl-reactive (GEM) T-cells. The roles of
other unconventional T-cells and iNKT cells in tissue
homeostasis, stress surveillance and autoimmunity are
well described elsewhere [4–6].
Unconventional T-cells: Not based on or
conforming to what is generally done or
believed (Oxford Dictionary)
Given the energetic costs of somatic recombination and
thymic selection (largely unproven for unconventional T-
cells), innate-like recognition by certain ab and gd T-
cells must confer a crucial evolutionary advantage. In this
respect, Vg9/Vd2 T-cells, MAIT cells and other uncon-
ventional T-cells effectively bridge the innate and adap-
tive immune systems by orchestrating acute inflammatory
responses and driving the generation of antigen-present-
ing cells [7,8,9]. Akin to the discrimination between ‘self’
and ‘non-self’ via TLR4-mediated recognition of lipo-
polysaccharide (LPS), a cell wall constituent of Gram-
negative bacteria, and TLR5-mediated recognition of
flagellin, a component of bacterial flagella, the metabolic
pathways targeted by Vg9/Vd2 T-cells, MAIT cells andCurrent Opinion in Immunology 2015, 36:31–37
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Innate sensing of microbial pathogens by Toll-like receptors and unconventional T-cell receptors. Pattern recognition of clinically relevant microbial
pathogens via TLR4 and TLR5, and TCRs expressed by Vg9/Vd2 T-cells, MAIT cells and GEM T-cells. Blue symbols, recognition; red symbols, no
recognition.GEM T-cells incorporate key structures that allow the
body to sense a wide range of potentially harmful micro-
organisms and trigger an inflammatory response aimed at
effective pathogen control (Figure 1). These biochemi-
cal determinants are absent from human cells and in-
clude ligands derived from the non-mevalonate
pathway, which generates the building blocks of all
higher isoprenoids in most Gram-negative bacteria
and many Gram-positive species (as well as the protozoa
Plasmodium falciparum and Toxoplasma gondii) [10], com-
ponents of the riboflavin pathway, which yields vitamin
B2 in the vast majority of bacteria as well as yeasts and
fungi [11], and certain long-chain fatty acids (mycolic
acids) found exclusively in the cell wall of mycobacteria
and coryneform bacteria [12]. Similar principles govern
the recognition of microbial a-linked glycolipids by
iNKT cells [5,6]. Many unconventional T-cells also
respond to cytokines such as IL-1b, IL-12, IL-18 and
IL-23 in a TCR-independent manner, and may there-
fore act similarly to NK cells and other innate lymphoid
cells [13–15].Current Opinion in Immunology 2015, 36:31–37 To facilitate innate sensing of microbial pathogens, un-
conventional human T-cells are thought to undergo
extrathymic and presumably antigen-driven expansion
in the periphery, consistent with a predominant central
or effector memory phenotype and the capacity to mount
rapid responses. Unconventional T-cells also localize
frequently to specific tissues and may therefore play a
role in local immune surveillance. Intriguingly, human
Vg9/Vd2 T-cell and MAIT cell numbers increase in
peripheral blood after birth and subsequently decline
in older individuals; they are also more prevalent in
women [16,17]. These observations could reflect age-
related and gender-dependent exposure to environmen-
tal, commensal and/or pathogenic species. However, re-
cent studies show that both Vg9/Vd2 T-cells and MAIT
cells acquire their anti-microbial responsiveness during
fetal development, prior to contact with environmental
microbes and commensal microflora [18,19]. Of note, an
age-related decline associated with changes in peripheral
subset composition has also been reported for iNKT
cells [20].www.sciencedirect.com
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Recognition of microbial metabolites by unconventional T-cells. (a) ‘Presentation’ of HMB-PP to the Vg9/Vd2 TCR in a BTN3-dependent manner:
1, Uptake of soluble HMB-PP released by extracellular bacteria, phagocytes or infected cells, via endocytosis and/or active/passive transport
across the cell membrane (e.g. E. coli); 2, Transport of HMB-PP from endocytic vesicles across the membrane after phagocytosis or infection (e.g.
Mycobacterium tuberculosis); 3, Release of HMB-PP into the cytosol by intracellular pathogens (e.g. Salmonella spp.); 4, Putative intracellular
loading compartment for BTN3. High affinity ligand: HMB-PP, (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate; low affinity ligand: IPP,
isopentenyl pyrophosphate. Note that HMB-PP is a microbial metabolite, whereas IPP is present in all prokaryotic and eukaryotic cells. (b)
Presentation of vitamin B2 metabolites to the MAIT TCR by MR1: 1, Uptake of soluble vitamin B2 metabolites released by extracellular bacteria,
phagocytes or infected cells; 2, Shuttling of vitamin B2 metabolites to late endosomes; 3, Release of vitamin B2 metabolites into the cytosol; 4,
MR1 loading compartment. High affinity ligand: 5-OP-RU, 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil; low affinity ligand: RL-6,7-diMe, 6,7-
dimethyl-8-D-ribityllumazine. APC, antigen-presenting cell; PMN, polymorphonuclear cell; IgV, immunoglobulin-like V ectodomain; IgC,
immunoglobulin-like C ectodomain; LL, di-leucine motif; b2M, b2-microglobulin; li, MHC class II-associated invariant chain (CD74).Vg9/Vd2 T-cells: Antigen presentation without
presentation of an antigen?
Peripheral blood Vg9/Vd2 T-cells carrying a TRGV9/
TRGJP-encoded TCRg chain normally constitute 1–5%
of the circulating T-cell population in humans but can
increase in frequency to >50% during microbial infec-
tions. Despite their prevalence in blood, these cells
mobilize rapidly to mucosal surfaces, where they may
confer protection against tissue-localized infections [21].
Vg9/Vd2 T-cells display a striking responsiveness to
bacterial species capable of producing the isoprenoid
precursor (E)-4-hydroxy-3-methyl-but-2-enyl pyrophos-
phate (HMB-PP) in vitro and in vivo [9,22] (Figure 2).
In patients infected with a range of pathogens, HMB-PP-
producing organisms are associated with higher Vg9/Vd2
T-cell frequencies than HMB-PP-deficient species. This
appears to be true both for local responses at the site of
infection, as demonstrated in patients with acute bacterialwww.sciencedirect.com peritonitis [1,10], and for systemic responses during
acute sepsis [7]. These clinical observations are backed
up by studies in macaques, where an HMB-PP-deficient
vaccine strain of Listeria monocytogenes elicited significant-
ly reduced pulmonary and systemic Vg9/Vd2 T-cell
responses compared with the HMB-PP-producing paren-
tal strain [23]. Similarly, an HMB-PP-overproducing
vaccine strain of Salmonella enterica serovar Typhimurium
stimulated prolonged Vg9/Vd2 T-cell expansions in rhe-
sus monkeys, while the avirulent parental strain was less
efficient in this respect [24].
The unique responsiveness of Vg9/Vd2 T-cells to HMB-
PP remains enigmatic as it appears to embody the only
case where an antigen is not actually presented to the
TCR but instead binds intracellularly to an innate sensor
(butyrophilin 3; BTN3/CD277) (Figure 2). Although
Vg9/Vd2 T-cells are generally portrayed as a populationCurrent Opinion in Immunology 2015, 36:31–37
34 Host pathogensunique to primates and absent in rodents, immunogenetic
studies point to a co-evolution of the Vg9 and Vd2 genes
together with BTN3 in other placental mammals such as
alpacas [25]. However, functional proof for the presence of
HMB-PP-specific and BTN3-dependent Vg9/Vd2 T-cells
in these species is still lacking. Following the pioneering
discovery of BTN3 as a restriction element for human Vg9/
Vd2 T-cell responses [26,27] and the observation that
anti-BTN3 agonist antibodies and soluble phosphoanti-
gens induce identical signaling pathways [28], at least four
independent studies have provided evidence for direct
binding of HMB-PP to a positively charged pocket in the
cytosolic B30.2 (PRYSPRY) domain of BTN3A1
[29,30,31,32]. These findings contradict an alternative
model proposing that HMB-PP binds to the extracellular
IgV domain of BTN3A1 and is therefore a truly presented
antigen [27]. Despite this convergence of experimental
data, it remains entirely unclear how the Vg9/Vd2 TCR
actually recognizes the BTN3A1/HMB-PP complex. In-
side the cell, HMB-PP sensing might be accompanied by
interaction partners such as periplakin, which binds a di-
leucine motif located proximal to the cytoplasmic B30.2
domain of BTN3A1 [32]. These intracellular events may
subsequently propagate across the cell membrane and
induce conformational changes on the cell surface [33],
possibly in combination with co-factors or clustering
effects that enable recognition by Vg9/Vd2 TCRs. Never-
theless, it is challenging to reconcile how the detection of a
seemingly ubiquitous and non-polymorphic molecule such
as BTN3A1 is facilitated through a rearranged TCR.
MAIT cells: Unconventional pathogen-sensing
through conventional TCR diversity?
MAIT cells are innate-like T-cells that populate mucosal
tissues such as the intestine and lung, comprising in
addition up to 10% of the circulating CD8+ ab T-cell
compartment and as many as half of all T-cells present in
the liver [34]. They share phenotypic similarities with
iNKT cells, express IL-12Rb2 and IL-18Ra alongside
high levels of CD161 [14,35], and localize to sites of
infection via chemokine receptors such as CCR2,
CCR6 and CXCR6 [35,36]. Unlike conventional ab T-
cells, MAIT cells possess thymic effector functionality
despite a naı¨ve phenotype [34] and are selected by
hematopoietic cells [37]. They subsequently expand in
the periphery as antigen-experienced, effector memory
T-cells upon microbial exposure [36,37]. Of note, the
presence of an intact commensal flora and expression of
the non-polymorphic MHC-related protein 1 (MR1) by
B-cells are both essential for this peripheral expansion,
whereas macrophages and dendritic cells are dispensable
[37]. Recent data have also revealed an essential role for
STAT3 signaling downstream of IL-21R and IL-23R in
controlling human MAIT cell numbers [38].
Pathogen recognition by human MAIT cells is driven by
a semi-invariant MR1-restricted TCR that typicallyCurrent Opinion in Immunology 2015, 36:31–37 incorporates a TRAV1-2/TRAJ33 (Va7.2-Ja33) TCRa
chain paired predominantly with a TRBV20-1 (Vb2) or
TRBV6 (Vb13) TCRb chain. Infrequent usage of other
TRAJ and TRBV gene segments has also been described
[3,39]. Unlike MHC class I-restricted epitopes, MAIT
cell ligand presentation by MR1 is independent of
proteasomal degradation and the transporter associated
with antigen processing (TAP), but requires the MHC
class II chaperones invariant chain (li) and HLA-DM
[40]. After initial observations that both human and
murine MAIT cells respond to species such as enter-
obacteria, staphylococci and mycobacteria, but not to
streptococci [7,36], key mechanistic advances have
shown that MAIT TCRs recognize ligands derived from
microbial vitamin B2 metabolism [11,41,42] (Figure 2).
Recent analyses have also revealed that the MAIT cell
repertoire is more diverse than initially thought [43,44],
which may allow these cells to discriminate between
different microbial pathogens via TCR-dependent
‘sensing’ of distinct MR1-bound ligands [39,44]. These
findings suggest the existence of other, as yet undiscov-
ered, microbial antigens within the MAIT cell recogni-
tion spectrum, a possibility consistent with structural
interpretations of MR1 ligand promiscuity [41,45–47].
However, a recent study in mice has challenged this idea
of ligand discrimination  via the TCRb chain [48], which
may point to species-specific differences between hu-
man and murine MAIT cells.
Patients with severe sepsis display an early decrease in
circulating MAIT cells compared with healthy controls
and uninfected critically ill patients [49]. In particular,
non-streptococcal bacterial infection was identified as an
independent determinant of peripheral MAIT cell de-
pletion, suggesting recruitment to the site of infection in
response to pathogens with an intact riboflavin pathway
[36,50,51]. In HIV-1 infection, circulating Va7.2+
CD161+ T-cells are depleted and fail to recover with
antiretroviral therapy [52,53]. This may indicate a pro-
gressive translocation of MAIT cells to peripheral tissues,
down-regulation of CD161, functional exhaustion and/or
activation-induced apoptosis. In a number of autoim-
mune and metabolic disorders, MAIT cells typically
display similarly decreased levels in peripheral blood
[54–56], possibly as a result of low-grade inflammation
and alterations of the microbiota.
Other pathogen-specific unconventional
T-cells: GEM T-cells and beyond
The MHC class I-related molecule CD1b was found
almost 20 years ago to present bacterial glycolipids such
as glucose monomycolate (GMM), yet the identity and
specificity of CD1b-restricted T-cells has remained elu-
sive until recently [57]. Mycolic acids (MAs) are the
predominant cell wall lipids in Mycobacterium tuberculosis
and represent a major virulence factor for this pathogen.
Rare MA-specific T-cells are detectable in tuberculosiswww.sciencedirect.com
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BCG-vaccinated individuals [58]. These T-cells are
CD1b-restricted, exhibit both central and effector mem-
ory phenotypes, produce IFN-g and IL-2 upon stimula-
tion, and appear to localize preferentially at the site of
infection. The availability of CD1b tetramers allowed
direct visualization of MA-specific T-cells, which were
estimated to comprise approximately 0.01% of all circu-
lating T-cells [59]. These advances eventually led to the
description of CD1b-restricted T-cells as Va7.2+ CD4+
germline-encoded mycolyl-reactive (GEM) T-cells,
which carry an invariant TRAV1-2/TRAJ9 TCRa chain
[12]. MA-specific T-cells were also shown to decline
after successful treatment and therefore appear to corre-
late with pathogen burden [58], emphasizing the poten-
tial importance of these unconventional T-cells as novel
diagnostic and prognostic biomarkers of tuberculosis.
As mycolic acids are a hallmark of all Corynebacteriales, it
is tempting to speculate that MA-specific T-cells may also
sense infections caused by bacteria such as Corynebacteri-
um spp. and Nocardia spp. (Figure 1). Of note, a second
population of GMM-specific T-cells has been identified
recently. These cells exhibit lower avidities for CD1b
tetramers and, in contrast to GEM T-cells, express TCRs
with a marked preference for the TRAV17 and TRBV4-1
genes [60]. High throughput sequencing of TRAV1-2+
TCRa chains further suggests that we are only seeing the
tip of the iceberg with regard to our knowledge of
unconventional T-cell populations [3]. It therefore seems
likely that many exciting discoveries will ensue in this
hybrid field.
Conclusions and future directions
The last three years have witnessed major advances in our
understanding of unconventional T-cell subsets, in part
due to the skillful application of cutting-edge experimen-
tal techniques to well-defined patient cohorts. Future
research can now build on this foundation to define the
true extent of these T-cell populations and define the
mechanisms that underlie microbial pattern recognition
within the adaptive immune system. Many questions
remain in this regard. Precisely how do unconventional
TCRs interact with non-polymorphic presenting mole-
cules? Are specific gene segments within the TCR locus
conserved for this purpose? Does the process of somatic
recombination serve to diversify bound ligand recogni-
tion? Do unconventional T-cells undergo positive selec-
tion in the thymus and does this process involve the
engagement of endogenous ligands? What are the molec-
ular processes involved in antigen uptake and intracellu-
lar trafficking that allow the presentation of microbial
metabolites?
Key pieces of the puzzle are also missing at the functional
level. How do unconventional T-cells migrate to and from
sites of infection? Do they persist as tissue-residentwww.sciencedirect.com memory-like cells after pathogen clearance? What is
the role of the commensal microbiota? Why do most
unconventional T-cells possess a memory phenotype
from early life? What mechanisms underlie the pro-
nounced age and gender bias? Are there implications
for homeostasis and susceptibility to infections, autoim-
munity and malignancy? How do accessory molecules
such as CD4, CD8, CD161 and NKG2D contribute in
this setting?
It is becoming increasingly clear that unconventional T-
cells play a pivotal role in the orchestration of early
inflammatory responses. In parallel, emerging mechanis-
tic insights have started to unlock the secrets of innate-
like recognition encoded by specific portions of the TCR
repertoire. The highly constrained genetic and microbial
elements inherent within each of these various systems
potentially offer unique molecular targets for the devel-
opment of novel and universally applicable diagnostics,
vaccines and immunotherapeutics. The overarching
question is therefore, as always, a humanitarian one.
How can we best harness the unique attributes of uncon-
ventional T-cells to combat the infectious and malignant
plagues of our times?
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